Free Trial

BioNTech (BNTX) SEC Filings & 10K Form

BioNTech logo
$113.51 +0.43 (+0.38%)
(As of 05:45 PM ET)

Recent BioNTech SEC Filings

DateFilerForm TypeView
12/13/2024
4:56 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
4:25 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
5:35 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
4:57 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
4:50 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
5:37 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:06 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
6:38 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
5:49 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
5:53 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
5:57 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/18/2024
8:04 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
4:03 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
7:41 AM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:15 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2024
3:13 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
3:24 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
3:17 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
4:14 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
5:18 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2024
7:12 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
3:52 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/27/2024
4:12 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/25/2024
6:14 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
8:17 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
6:28 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:35 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
7:53 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/22/2024
3:31 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
7:34 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/16/2024
5:56 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/05/2024
5:32 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/05/2024
5:34 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2024
8:08 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
7:07 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
6:18 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
6:46 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
3:36 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2024
6:18 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2024
5:48 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
4:05 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)

You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.

Click Here to get the full details about Crypto’s Hidden Gem
04/08/2024
6:12 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
6:57 AM
BioNTech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/20/2024
6:33 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
6:11 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
8:04 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
7:41 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2024
5:26 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
6:26 AM
BioNTech (Subject)
Medine GmbH (Filed by)
Form SC 13G/A
02/08/2024
5:08 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2024
4:03 PM
ATHOS KG (Filed by)
BioNTech (Subject)
Form SC 13G/A
01/31/2024
6:47 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2024
8:14 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/09/2024
6:01 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/04/2024
7:02 AM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BNTX) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners